Regeneron Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y., Dec. 16, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc., (NASDAQ: REGN) will webcast its presentation at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021. The presentation is scheduled for 8:20 a.m. Eastern Time and may be accessed from the "Investors & Media" page of Regeneron's website at http://investor.regeneron.com/events.cfm. An archived version of the webcast will be available for at least 30 days.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
SOURCE Regeneron Pharmaceuticals, Inc.
Company Codes: NASDAQ-NMS:REGN